Line 36: | Line 36: | ||
<p class="paragraph-medium">We have validated our [BioBrick #1] and documented its characterization in the iGEM Parts Registry found on our Parts page with an explanation of its utility.</p></li> | <p class="paragraph-medium">We have validated our [BioBrick #1] and documented its characterization in the iGEM Parts Registry found on our Parts page with an explanation of its utility.</p></li> | ||
<li>Collaboration | <li>Collaboration | ||
− | <p class="paragraph-medium">Our collaborations with three different Ontario universities in Canada is outlined on our <a href="https://2016.igem.org/Team:Waterloo/Collaboration"> | + | <p class="paragraph-medium">Our collaborations with three different Ontario universities in Canada is outlined on our <a href="https://2016.igem.org/Team:Waterloo/Collaboration">Collaboration</a> page.</p></li> |
<li>Human Practices | <li>Human Practices | ||
<p class="paragraph-medium">Our Policy and Practices team has delved into multiple areas beyond the lab like the ethics, social justice, and intellectual property rights of our project and the overarching synthetic biology used in it. In addition, our special project looking at the 2015 iGEM collaboration network has revealed some issues. Please see our <a href ="">Practices Overview</a> page for details.</p></li> | <p class="paragraph-medium">Our Policy and Practices team has delved into multiple areas beyond the lab like the ethics, social justice, and intellectual property rights of our project and the overarching synthetic biology used in it. In addition, our special project looking at the 2015 iGEM collaboration network has revealed some issues. Please see our <a href ="">Practices Overview</a> page for details.</p></li> |
Revision as of 02:17, 12 October 2016
- Register and Attend
We are registered and will be attending the Giant Jamboree Oct. 27-31, 2016.
- Deliverables
We did this.
- Attributions
The work done by the students on the Waterloo iGEM team and the assistance we received from our advisors, iGEM teams, graduate students, and many other is displayed on our Attributions page.
- Parts/Contribution
We have added our two BioBricks [BioBrick#1 and BioBrick#2] with documentation on the iGEM Parts Registry. How these parts are used Is discusssed on the Parts page.
- Validated Part
We have validated our [BioBrick #1] and documented its characterization in the iGEM Parts Registry found on our Parts page with an explanation of its utility.
- Collaboration
Our collaborations with three different Ontario universities in Canada is outlined on our Collaboration page.
- Human Practices
Our Policy and Practices team has delved into multiple areas beyond the lab like the ethics, social justice, and intellectual property rights of our project and the overarching synthetic biology used in it. In addition, our special project looking at the 2015 iGEM collaboration network has revealed some issues. Please see our Practices Overview page for details.
- Integrated Human Practices
We integrated our Human Practices activities into our project where details can be found on the Practices Overview page. Moreover, our special investigation on the 2015 iGEM collaborations network issues yielded important results we highly recommend for other iGEM teams where details can also be found on the Practices Overview page.
- Improve a Previous Part or Project
Building on last year’s BBa_K1645998 BioBrick, we improved its characterization with more robust flow cytometry experiments demonstrating the modified sgRNA’s ability to repress the LacI promoter upstream of an RFP. The related documented information can be found here.
- Demonstrate Your Work
We demonstrate our proof-of-concept, novel regulatory element functions on our Results page.